Morgan Securities LLC is acting as exclusive financial advisor to Qualitest Pharmaceuticals and Kirkland & Ellis LLP is acting as Qualitest Pharmaceuticals’ legal counsel. The transaction is subject to regulatory review, including clearance by the relevant antitrust authorities, and is expected to close late in the fourth quarter of 2010 or early in the first quarter of 2011. I am convinced that this combination will enable our management team and employees to accelerate the growth of our business and continue the important work we do here at Qualitest.” I am confident Qualitest’s unique capabilities as a leading generics provider ideally complement Endo’s diversified businesses.
Today’s announcement brings together two highly successful businesses that I believe are an excellent fit. Marvin Samson, Chairman and Chief Executive Officer of Qualitest Pharmaceuticals, commented, “Apax has been an exceptional partner for the Qualitest team since 2007, and we thank them for their contributions as we grew the company while maintaining our unwavering dedication to compliance. Qualitest, and now Endo, represents an important part of the solution to the challenges faced by the U.S. by supplying high-quality, cost-effective pharmaceuticals. Qualitest, a portfolio company of Apax Partners since 2007, is the sixth largest generic pharmaceutical company in the U.S.īuddy Gumina, Partner and Co-Head of Global Healthcare at Apax, said, "We have been proud to work with the management team at Qualitest Pharmaceuticals over the past three years as they have built one of the leading generics businesses in the U.S. New York, Septem– Apax Partners today announced that Endo Pharmaceuticals (Nasdaq: ENDP) has entered into a definitive agreement to acquire Qualitest Pharmaceuticals for approximately $1.2 billion in cash. Apax Partners to Sell Qualitest Pharmaceuticals to Endo Pharmaceuticals for $1.2 Billion 29th September 2010 Apax New York, Septem– Apax Partners today announced that Endo Pharmaceuticals (Nasdaq: ENDP) has entered into a definitive agreement to acquire Qualite Most pharmaceutical companies have better annual bonuses and special rewards for their employees compared to this company.Home > News & Views > Apax Partners to Sell Qualitest Pharmace. Also, people get burned out because they have to give so much of themselves with little return. The workplace culture is not the best, because of a lack of clear communication over the years.
I have learned to keep pressing forward to find my niche in the company and have been entrusted with several projects that I was able to work on independently. That's just a part of working in a GMP environment. The fast pace of pharmaceuticals fits my personality and drive although it does become difficult at times to have to be so precise and document each mistake so thoroughly. I have enjoyed my work here, because although a lot of days might seem the same, I have worked with a great group of people. Even though I consistently did outstanding work and did all of the duties of a supervisor, I was not promoted in title which was disappointing. I have been able to flex hours around personal needs and the benefits are great, but the pay could be better. I gave the company an overall 3 stars, because that is average in my opinion.
0 kommentar(er)
